CONCENTRIX CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $9.83B | $9.62B | $7.11B | $6.32B | $5.59B | $4.72B | $4.71B |
| Cost of Revenue | $6.39B | $6.17B | $4.54B | $4.07B | $3.62B | $3.06B | $2.96B |
| Gross Profit | $3.44B | $3.45B | $2.58B | $2.26B | $1.97B | $1.66B | $1.75B |
| Gross Margin | 35.0% | 35.9% | 36.2% | 35.7% | 35.3% | 35.2% | 37.1% |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $2.83B | $2.85B | $1.92B | $1.62B | $1.40B | $1.35B | $1.45B |
| Operating Income | $-918.2M | $596.4M | $661.3M | $640.2M | $572.4M | $308.8M | $294.3M |
| Operating Margin | -9.3% | 6.2% | 9.3% | 10.1% | 10.2% | 6.5% | 6.3% |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | $-1.18B | $299.3M | $408.2M | $605.0M | $555.7M | $267.9M | $204.4M |
| Income Tax Expense | $96.7M | $48.1M | $94.4M | $169.4M | $150.1M | $103.1M | $87.3M |
| Net Income | $-1.28B | $251.2M | $313.8M | $435.0M | $405.6M | $164.8M | $117.2M |
| Net Margin | -13.0% | 2.6% | 4.4% | 6.9% | 7.3% | 3.5% | 2.5% |
| EPS (Basic) | $-20.36 | $3.72 | $5.72 | $8.34 | $7.78 | $3.19 | $2.27 |
| EPS (Diluted) | $-20.36 | $3.71 | $5.70 | $8.28 | $7.70 | $3.19 | $2.27 |
| Shares Outstanding (Basic) | 63.0M | 65.0M | 53.8M | 51.4M | 51.4M | 51.6M | 51.6M |
| Shares Outstanding (Diluted) | 63.0M | 65.1M | 54.0M | 51.7M | 51.9M | 51.6M | 51.6M |
| Dividends Per Share | — | — | — | — | — | — | — |